BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 30057636)

  • 1. The effect of pregabalin and duloxetine treatment on quality of life of breast cancer patients with taxane-induced sensory neuropathy: A randomized clinical trial.
    Avan R; Janbabaei G; Hendouei N; Alipour A; Borhani S; Tabrizi N; Salehifar E
    J Res Med Sci; 2018; 23():52. PubMed ID: 30057636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the Efficacy and Safety of Pregabalin and Duloxetine in Taxane-Induced Sensory Neuropathy: A Randomized Controlled Trial.
    Salehifar E; Janbabaei G; Hendouei N; Alipour A; Tabrizi N; Avan R
    Clin Drug Investig; 2020 Mar; 40(3):249-257. PubMed ID: 31925721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lidocaine Infusion Versus Duloxetine for Prevention and Management of Taxane-Induced Peripheral Neuropathy among Breast Cancer Patients-A Randomized Controlled Study.
    Abouelmagd GMT; El-Karadawy SA; Abo-Ollo MM; Elwany YN; Mohamed ER; El-Amrawy WZ
    Pain Physician; 2023 Sep; 26(5):E497-E507. PubMed ID: 37774185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of taxane-induced peripheral neuropathy receiving treatment and prescription patterns in patients with breast cancer.
    Song SJ; Min J; Suh SY; Jung SH; Hahn HJ; Im SA; Lee JY
    Support Care Cancer; 2017 Jul; 25(7):2241-2248. PubMed ID: 28204996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Taxane-induced peripheral neuropathy and quality of life in breast cancer patients.
    Salehifar E; Janbabaei G; Alipour A; Tabrizi N; Avan R
    J Oncol Pharm Pract; 2020 Sep; 26(6):1421-1428. PubMed ID: 31937190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment by adding duloxetine to pregabalin for peripheral neuropathy induced by paclitaxel.
    Takenaka M; Iida H; Matsumoto S; Yamaguchi S; Yoshimura N; Miyamoto M
    Am J Hosp Palliat Care; 2013 Nov; 30(7):734-6. PubMed ID: 23064035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Prospective Observational Study Comparing the Efficacy and Safety of Duloxetine and Pregabalin in Diabetic Peripheral Neuropathic Pain.
    Shah I; Ahmad W; Islam M; Jan B; Ul Haq E; Mahmood J; Iqbal N; Shah M
    Cureus; 2022 Sep; 14(9):e28683. PubMed ID: 36199645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of persistent peripheral neuropathy on health-related quality of life among early-stage breast cancer survivors: a population-based cross-sectional study.
    Engvall K; Gréen H; Fredrikson M; Lagerlund M; Lewin F; Åvall-Lundqvist E
    Breast Cancer Res Treat; 2022 Oct; 195(3):379-391. PubMed ID: 35941422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating the effects of duloxetine on prophylaxis of oxaliplatin-induced peripheral neuropathy in patients with gastrointestinal cancer: A randomized double-blind placebo controlled clinical trial.
    Rokhsareh S; Haghighi S; Tavakoli-Ardakani M
    J Oncol Pharm Pract; 2023 Jan; 29(1):60-65. PubMed ID: 34738855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the Efficacy of Duloxetine and Pregabalin in Pain Relief Associated with Diabetic Neuropathy.
    Shahid W; Kumar R; Shaikh A; Kumar S; Jameel R; Fareed S
    Cureus; 2019 Jul; 11(7):e5293. PubMed ID: 31579634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerability of pregabalin using a flexible, optimized dose schedule in Korean patients with peripheral neuropathic pain: a 10-week, randomized, double-blind, placebo-controlled, multicenter study.
    Moon DE; Lee DI; Lee SC; Song SO; Yoon DM; Yoon MH; Kim HK; Lee YW; Kim C; Lee PB
    Clin Ther; 2010 Dec; 32(14):2370-85. PubMed ID: 21353106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study on comparative efficacy and cost effectiveness of Pregabalin and Duloxetine used in diabetic neuropathic pain.
    Roy MK; Kuriakose AS; Varma SK; Jacob LA; Beegum NJ
    Diabetes Metab Syndr; 2017; 11(1):31-35. PubMed ID: 27484440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum sodium ions and chloride ions associated with taxane-induced peripheral neuropathy in Chinese patients with early-stage breast cancer: A nation-wide multicenter study.
    Zhai J; Sun X; Zhao F; Pan B; Li H; Lv Z; Cao M; Zhao J; Mo H; Ma F; Xu B
    Breast; 2023 Feb; 67():36-45. PubMed ID: 36586272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duloxetine, pregabalin, and duloxetine plus gabapentin for diabetic peripheral neuropathic pain management in patients with inadequate pain response to gabapentin: an open-label, randomized, noninferiority comparison.
    Tanenberg RJ; Irving GA; Risser RC; Ahl J; Robinson MJ; Skljarevski V; Malcolm SK
    Mayo Clin Proc; 2011 Jul; 86(7):615-26. PubMed ID: 21719618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of duloxetine in Chinese breast cancer patients with paclitaxel-induced peripheral neuropathy.
    Wang J; Li Q; Xu B; Zhang T; Chen S; Luo Y
    Chin J Cancer Res; 2017 Oct; 29(5):411-418. PubMed ID: 29142460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Additive Duloxetine for Cancer-Related Neuropathic Pain Nonresponsive or Intolerant to Opioid-Pregabalin Therapy: A Randomized Controlled Trial (JORTC-PAL08).
    Matsuoka H; Iwase S; Miyaji T; Kawaguchi T; Ariyoshi K; Oyamada S; Satomi E; Ishiki H; Hasuo H; Sakuma H; Tokoro A; Shinomiya T; Otani H; Ohtake Y; Tsukuura H; Matsumoto Y; Hasegawa Y; Kataoka Y; Otsuka M; Sakai K; Matsuda Y; Morita T; Koyama A; Yamaguchi T
    J Pain Symptom Manage; 2019 Oct; 58(4):645-653. PubMed ID: 31254640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent taxane-induced neuropathy in elderly patients treated for localized breast cancer.
    Pabst L; Velten M; Fischbach C; Kalish M; Pflumio C; Pivot X; Petit T
    Breast J; 2020 Dec; 26(12):2376-2382. PubMed ID: 33307596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations (PAIN-CONTRoLS): Bayesian Adaptive Comparative Effectiveness Randomized Trial.
    Barohn RJ; Gajewski B; Pasnoor M; Brown A; Herbelin LL; Kimminau KS; Mudaranthakam DP; Jawdat O; Dimachkie MM; ; Iyadurai S; Stino A; Kissel J; Pascuzzi R; Brannagan T; Wicklund M; Ahmed A; Walk D; Smith G; Quan D; Heitzman D; Tobon A; Ladha S; Wolfe G; Pulley M; Hayat G; Li Y; Thaisetthawatkul P; Lewis R; Biliciler S; Sharma K; Salajegheh K; Trivedi J; Mallonee W; Burns T; Jacoby M; Bril V; Vu T; Ramchandren S; Bazant M; Austin S; Karam C; Hussain Y; Kutz C; Twydell P; Scelsa S; Kushlaf H; Wymer J; Hehir M; Kolb N; Ralph J; Barboi A; Verma N; Ahmed M; Memon A; Saperstein D; Lou JS; Swenson A; Cash T
    JAMA Neurol; 2021 Jan; 78(1):68-76. PubMed ID: 32809014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective chart review of duloxetine and pregabalin in the treatment of painful neuropathy.
    Mittal M; Pasnoor M; Mummaneni RB; Khan S; McVey A; Saperstein D; Herbelin L; Ridings L; Wang Y; Dimachkie MM; Barohn RJ
    Int J Neurosci; 2011 Sep; 121(9):521-7. PubMed ID: 21671841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between pain relief and improvements in patient function/quality of life in patients with painful diabetic peripheral neuropathy or postherpetic neuralgia treated with pregabalin.
    Vinik A; Emir B; Cheung R; Whalen E
    Clin Ther; 2013 May; 35(5):612-23. PubMed ID: 23541708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.